Non-financial interests, and the conflicts of interest that may result from them, are frequently overlooked in biomedicine. This is partly due to the complex and varied nature of these interests, and the limited evidence ...

In 2016, the Office of the State Coroner of New South Wales released its report into the death of an Australian woman, Sheila Drysdale, who had died from complications of an autologous stem cell procedure at a Sydney clinic. ...

This was how the final morning in the life of Dr John Elliot was reported on the front page of the Sydney Morning Heraldin January 2007. Dr Elliot, from NSW, was gravely ill with multiple myeloma, and had travelled ...

Researchers studying health care decision making generally focus on the interaction that unfolds between patients and health professionals.Using the example of allogeneic bone marrow transplant, in this article we identify ...

Decisions to withhold cardio-pulmonary resuscitation (CPR) should provide explicit clinical and ethical justification, be stated in an unambiguous manner, and be formally documented in the medical chart. Even so, the legal ...

“Sunshine” policy, aimed at making financial ties between health professionals and industry publicly transparent, has recently gone global. Given that transparency is not the sole means of managing conflict of interest, ...

Should children conceived through the use of donated gametes have access to information identifying their donors when they reach maturity? The UK Government is expected soon to decide that, from now on, the answer to this ...

Overdiagnosis is an emerging problem in health policy and practice: we address its definition and ethical implications. We argue that the definition of overdiagnosis should be expressed at the level of populations. Consider ...

In this paper we examine some of the main features of public discourse concerning tobacco control, analysing parliamentary debate in New South Wales between 1980 and 2003. We ask both how deeply tobacco industry discursive ...

Patients deserve timely access to new therapies, but the rhetoric surrounding accelerated access impedes rational policy making.It is almost impossible to turn on the television or open a newspaper without hearing about ...